Clinical trials
Treatment clinical trials
Below are recruiting treatment clinical trials, each written for real people, not researchers. We’re tracking 8,313 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06972368Recruiting
Home brain stimulation for depression in borderline personality disorder
This trial tests whether a gentle brain stimulation device (tDCS) used at home can help with depression in people with borderline personality disorder. If you have BPD and current depression, you may be able to participate from home using your smartphone.
Montreal, QuebecAges 18–65 - NCT06968533Enrolling by invitation
AI ECG for detecting low heart pumping in older adults
This trial uses an AI tool to analyze your ECG (heart tracing) to detect low pumping function. It may help find hidden heart issues early, especially if you haven't had a recent heart ultrasound.
TaipeiAges 60–85 - NCT06963801Recruiting
DBT for emotional challenges during pregnancy
This study tests whether a therapy called Dialectical Behavior Therapy (DBT) can help pregnant people who struggle with strong emotions. If you are at least 12 weeks pregnant and find it hard to manage your feelings, you may be able to join.
Durham, North CarolinaAges 18–45 - NCT06967545Recruiting
Smartphone program to help with suicidal thoughts
This trial tests a smartphone-based program designed to help people who have frequent suicidal thoughts. It aims to provide support through your phone, so you can get help when you need it.
Boston, MassachusettsAges 18 years+ - NCT06964737RecruitingPhase 1
CAR T-cell therapy for recurrent brain tumors
This trial tests a new type of immunotherapy called CAR T-cells that target a protein called GARP on your tumor cells. It is for people whose high-grade glioma (a fast-growing brain tumor) has come back after previous treatment.
Columbus, OhioAges 18 years+ - NCT06971354Recruiting
Treatment for rumination syndrome
This trial tests a treatment for rumination syndrome, a condition where food is brought back up from the stomach into the mouth. It may help if you have this syndrome and no other major medical issues.
BarcelonaAges 18–75 - NCT06964620RecruitingEarly Phase 1
Sanggua tablets for early type 2 diabetes or prediabetes
This trial tests whether an herbal medicine called Sanggua tablets can help control blood sugar in people with prediabetes or mild type 2 diabetes who are not yet taking diabetes pills. If you have slightly high blood sugar but don't need medication yet, this study may help you manage it naturally.
Wuhan, HubeiAges 18–70 - NCT06969521Recruiting
Online speech therapy for kids who struggle with the R sound
This trial tests a new online treatment program designed to help children and teens improve their production of the R sound. It may be a good option if your child has difficulty saying the R sound and speaks English as their main language.
Montclair, New JerseyAges 8–17 - NCT06969755RecruitingPhase 4
Brain scans and genetics to guide early schizophrenia treatment
This study tests whether using brain scans and genetic tests can help choose the best treatment for people early in their schizophrenia. It will check if these biomarkers can predict who will respond better to medication.
Birmingham, AlabamaAges 18–35 - NCT06967402Recruiting
Mouthwash study for gum disease treatment
This study tests two types of mouthwash to see which helps treat gum disease better when used with regular dental care. It may be a good option if you have moderate to severe gum disease and are generally healthy.
Hong KongAges 18 years+ - NCT06968676Recruiting
Mixed reality for arm rehab in multiple sclerosis
This trial tests if mixed reality (a blend of real and virtual environments) can improve arm and hand function in people with multiple sclerosis. It may help you move your arm better and with less stiffness.
Leganés, MadridAges 18 years+ - NCT05044403Recruiting
Hemoperfusion for severe sepsis causing multiple organ failure
This study tests whether a blood-filter treatment called hemoperfusion can help critically ill people with sepsis that is not responding to standard shock treatment and is affecting multiple organs. It aims to improve recovery when infections are controlled and inflammation markers are very high.
Castellon, CastellónAges 18–80 - NCT06515301Recruiting
Improving follow-up after cervical precancer treatment
This study in Ethiopia looks at ways to help women stay on track with follow-up visits after treatment for cervical precancer. It tests simple support methods to improve adherence.
Silte, Southern EthiopiaAges 25–49 - NCT06369714Recruiting
Brain-training video game for ADHD in children
This trial tests a digital therapy that uses neurofeedback (brainwave training) to help children with ADHD improve focus and attention. It's designed for kids ages 6 to 11 who haven't had ADHD treatment in the last month.
Shanghai, Shanghai MunicipalityAges 6–12 - NCT06850792Recruiting
Improving treatment adherence with telemedicine and guidance
This study tests whether regular remote check-ins and guidance can help people with pulmonary arterial hypertension stick to their treatment plan. You would be followed by phone or video from University of Sao Paulo.
São Paulo, São PauloAges 18 years+ - NCT06940960Recruiting
JY231 cell therapy for relapsed B-cell lymphoma or leukemia
This trial tests a new cell therapy (JY231) for people whose B-cell lymphoma or leukemia (B-ALL) has returned or not responded to earlier treatments. The therapy uses your own T cells, modified to target the CD19 marker on cancer cells.
Guangzhou, GuangdongAges 12–75 - NCT05928039RecruitingPhase 4
Choosing the best first biologic for Crohn’s in the ileum
This Phase 4 trial tests which type of biologic medicine works best as the first treatment for people with moderate-to-severe Crohn’s that mainly affects the ileum. It may help you and your care team choose a more effective first option, based on which strategy leads to better control of symptoms and intestinal inflammation.
Calgary, AlbertaAges 18 years+ - NCT05955001RecruitingPhase 2/Phase 3
Tadalafil for early urinary symptoms after prostate surgery
This trial studies whether daily tadalafil (5 mg) can improve early urinary trouble and erection function after endoscopic prostate tissue removal. It may help men whose urinary symptoms continued even after prior medicine.
Al Mansurah, Dakahlia GovernorateAges 40–80 - NCT06959251Recruiting
Glycine and magnesium with thiamine for primary ciliary dyskinesia
This trial tests whether a combination of glycine, magnesium, and thiamine can help people with primary ciliary dyskinesia (a condition that affects the tiny hairs in your lungs). It aims to see if these supplements improve breathing and reduce lung problems.
Mexico CityAges 5 years+ - NCT06952842RecruitingPhase 1/Phase 2
Gene therapy trial for retinitis pigmentosa with RHO mutation
This trial tests a new gene therapy called ZVS203e for people with retinitis pigmentosa caused by a specific RHO gene mutation. It aims to see if the treatment is safe and can help improve vision.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06959095RecruitingPhase 3
Depemokimab for adults with COPD and type 2 inflammation
This trial tests a new biologic medicine called depemokimab, given as an injection, to see if it reduces flare-ups (exacerbations) in people with COPD who have a specific type of inflammation (high eosinophils). It may help if you have frequent flare-ups despite using your regular inhalers.
Bakersfield, CaliforniaAges 40–80 - NCT06954246RecruitingPhase 3
New drug vs. doctor’s choice for relapsed small cell lung cancer
This trial tests a new drug called MHB088C for people with small cell lung cancer that has come back or gotten worse after standard treatments. It compares this drug to other options your doctor might choose. The goal is to see if MHB088C works better.
ShanghaiAges 18 years+ - NCT06956001RecruitingPhase 3
Testing firmanertinib vs chemo for first-line lung cancer with specific EGFR mutations
This trial compares a new targeted therapy pill (firmanertinib) to standard chemotherapy in people with advanced non-small cell lung cancer whose tumors have a specific EGFR mutation (PACC or L861Q). If you haven't had treatment for advanced disease and your cancer matches these mutations, this study may offer a more convenient oral option.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06961214RecruitingPhase 3
Depemokimab for COPD with type 2 inflammation
This study tests a new biologic medicine, given as an injection, to see if it can reduce flare-ups in adults with COPD who have a certain type of inflammation. It may help people who still have frequent exacerbations despite using their current inhalers.
Sheffield, AlabamaAges 40–80
Hear when a new Treatment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for treatment?
- Yes. Clin2 currently lists 8,313 recruiting treatment studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a treatment trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a treatment trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.